90%
of all deaths in Europe and Central Asia are due to noncommunicable diseases
Europe & Central Asia is the region most affected by noncommunicable diseases, with cardiovascular disease being responsible for more than half of all deaths across the region.
Europe and Central Asia have the highest prevalence of tobacco smoking among adults aged 15 and older as well as the highest alcohol consumption levels in the world.
4.2M
people die in the region every year because of CVD
Europe & Central Asia have the highest proportion of smokers in the world
Our Members
Georgian Heart Foundation
Latest News
WHF UN High-Level Meeting Statement on Health Systems Strengthening and Financing for NCDs
This statement was prepared by the World Heart Federation in response to the UN High-Level Meeting on NCDs panel discussion on Reshaping and Strengthening Health Systems and All Forms of Financing to Meet the Needs of People Living With and at Risk of Noncommunicable Diseases and Mental Health Conditions. Distinguished Delegates, Colleagues, and Partners, […]
WHF President Prof. Jagat Narula Delivers Key Statement at UN High-Level Meeting on NCDs and Mental Health
This statement was delivered by Prof. Jagat Narula, President of the World Heart Federation, at the UN High-Level Meeting on NCDs in response to the panel discussion on Tackling the Determinants of Noncommunicable Diseases and Mental Health and Well-Being Through Multisectoral and Effective Governance and Collaborative Action. Distinguished Delegates, Colleagues, and Partners, Cardiovascular disease […]
FH Awareness Day 2025
The World Heart Federation (WHF) is proud to stand with the international cardiovascular and FH communities in celebrating FH Awareness Day 2025. Familial Hypercholesterolemia (FH) is widely recognized as one of the most common inherited disorders globally, yet it remains critically underdiagnosed and undertreated. Heterozygous FH affects approximately 1 in 311 people worldwide – around […]
Familial hypercholesterolemia
Triple single-pill combinations and GLP-1 agonists: World Health Organization calls them “essential”.
Will the world listen?
Gautam Satheesh, 2024 Emerging Leader Gautam Satheesh is a Doctoral Researcher at the University of Sydney in Australia and a Research Associate at The George Institute for Global Health, India. Gautam is a World Heart Federation Emerging Leader (2024 cohort) and a Health System Global Emerging Voice for Global Health (EV4GH 2024). His research focuses on […]
